ArisGlobal Unveils Innovative LifeSphere Solutions at Breakthrough 2025 Event

On March 19, 2025, ArisGlobal, a prominent name in life sciences technology and the creator of LifeSphere®, showcased three cutting-edge solutions aimed at boosting pharmacovigilance and regulatory processes during its annual industry event, Breakthrough 2025 held in Zurich. This year’s theme, "AI in Action," focused on real-world applications of artificial intelligence in the life sciences sector.

Introducing LifeSphere Unify

The highlight of the announcements was the LifeSphere Unify Platform, which integrates data and workflows across safety, medical affairs, regulation, and quality management. This unified approach promises enhanced efficiency, ensuring compliance while promoting innovation within organizations. Powered by NavaX, this platform empowers users to accelerate time-to-market for treatments and make data-driven decisions with unparalleled interoperability, seamless scalability, and security. With its advanced features, LifeSphere Unify is set to transform clinical development and regulatory submission processes, promoting a more agile development framework.

The Power of NavaX Insights

ArisGlobal also introduced NavaX Insights, a powerful new feature that redefines how life sciences organizations extract actionable insights from complex and fragmented data in real time. Utilizing AI agents, NavaX Insights autonomously gathers, synthesizes, and contextualizes both proprietary and public information, creating new knowledge. This innovation enables companies to anticipate upcoming risks and regulatory challenges before they arise, identify hidden patterns overlooked by traditional analytics, and make quicker, smarter decisions in areas concerning pharmacovigilance and compliance.

Advanced Compliance Docs: Modernizing Compliance Processes

To further enhance compliance workflows, ArisGlobal launched Advanced Compliance Docs, which modernizes document management through intelligent, cloud-based solutions. This tool streamlines the creation, storage, and management of crucial documents like Pharmacovigilance System Master Files (PSMFs), Pharmacovigilance Agreements (PVAs), and aggregate reports including PSURs, PBRERs, and DSURs.
With Advanced Compliance Docs, companies can automate document management using customizable templates with auto-filled safety, approval, and clinical data, ensuring adherence to regulatory requirements and inspection readiness while meeting current industry standards. The efficient retrieval of important pharmacovigilance documents in a central, accessible repository further simplifies collaboration and accelerates approval workflows while minimizing compliance risks.

According to Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal, “We are excited to announce these new offerings as ArisGlobal continues to invest in the best applications that harness the latest AI technology. The LifeSphere Unify platform provides unparalleled value in data exchange and interoperability, allowing companies to seamlessly connect insights across the ecosystem. With NavaX Insights, we go beyond process automation to empower organizations to make smarter, data-driven decisions faster than ever. Similarly, Advanced Compliance Docs addresses the pharmaceutical industry's need to reevaluate its medical writing strategies to optimize costs and boost efficiency.”

ArisGlobal is at the forefront of responsible AI adoption, reinforcing its commitment to innovation with integrity. The company has recently signed the EU AI Pact, aligning with global best practices for the ethical use of AI in the life sciences sector.

Breakthrough 2025 brought together top executives, industry leaders, and experts to explore the significant role of artificial intelligence within the life sciences, showcasing revolutionary applications that are changing the landscape of healthcare.

For more information, visit ArisGlobal's official page or follow them on LinkedIn for regular updates.